Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis.
Journal: Nature communications
Published: March 06, 2025
Central Nervous System Prophylaxis Utilization in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Within a Large Community Health System.
Journal: Journal of patient-centered research and reviews
Published: July 24, 2024
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.
Journal: The Lancet. Oncology
Published: August 19, 2022
Practice Model for Advanced Practice Providers in Oncology.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 01, 2017
Best Practices and Practical Nuances in the Treatment of Gastric Cancer in High-Risk Global Areas.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 01, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026